Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals

Group revenue was €164.9 million in Q3 and €465.0 million for the first nine months, versus €164.2 million and €477.4 million, respectively, at constant exchange rates (CER). Adjusted Group EBITDA was -€1.6 million in Q3 and -€44.3 million for the nine months, compared with -€1.7 million and -€39.1 million at CER. Q3 results were broadly steady, while nine-month revenue and adjusted EBITDA were lower than the CER comparisons.